Alumis

Biopharma developing late-stage targeted therapies for immune-mediated diseases such as psoriasis

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Alumis

Alumis Inc. is a biopharmaceutical company focused on immune-mediated diseases. It advances a late-stage portfolio of next-generation targeted therapies, including envudeucitinib, for which it reported new Phase 3 data in psoriasis.

Its development approach combines integrated scientific insights with a proprietary data analytics platform. The company's stated customers are patients with immune-mediated diseases. The leadership team includes President and CEO Martin Babler, Chief Development Officer Mark Bradley and Chief Medical Officer Jörn Drappa.

The company publishes quarterly financial results and presents at investor conferences. Its current job openings are in clinical development and medical affairs, with roles in South San Francisco and across the United States.

Product: Late-stage targeted therapies for immune-mediated diseases, including envudeucitinib in psoriasis.

Jobs at Alumis

No open positions in Europe right now.

Open roles at Alumis in the Americas (2)

United States 2. From Alumis's careers page or applicant tracking system; each role links to the employer.

More biotech & pharma companies

  • Amgen

    Biotechnology medicines for patients with serious diseases, developed and supplied to healthcare markets worldwide
    United StatesBiotech & pharma101 open jobs
  • Amylyx Pharmaceuticals

    Develops investigational therapies for people with rare and serious diseases
    United StatesBiotech & pharma
  • Amyris

    Precision-fermentation and biomanufacturing services for companies developing renewable chemicals and ingredients
    Emeryville, United StatesBiotech & pharmaFounded 2003
    New on Evolc
  • Annexon Biosciences

    Develops C1q-targeting therapies for patients with complement-driven autoimmune, neurodegenerative and ophthalmic diseases
    United StatesBiotech & pharma
    New on Evolc
  • Anthrogen

    AI biology research lab developing programmable molecular tools and protein models for biological research and intervention
    United StatesBiotech & pharma
    New on Evolc
  • Arcaea

    Biotechnology research and beauty product development for the beauty industry and consumers
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Recruiting

  • GreenhouseMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.